The 35 references in paper A. Shevchenko V., O. Golovanova V., M. Kolomejtchuk Ju., V. Konenkov I., E. Garbukov Ju., M. Stakheeva N., А. Шевченко В., О. Голованова В., М. Коломейчук Ю., В. Коненков И., Е. Гарбуков Ю., М. Стахеева Н. (2014) “ПОЛИМОРФИЗМ ПРОМОТОРНОГО РЕГИОНА ГЕНОВ IL-4, IL-6 И IL-10 У ПАЦИЕНТОК С РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ // PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER” / spz:neicon:mimmun:y:2009:i:1:p:21-28

1
Бабышкина Н.Н., Стахеева М.Н., Слонимская Е.М., Чердынцева Н.В., Гарбуков Е.Ю. Иммунологические параметры и уровень продукции цитокинов у больных с пролиферативными заболеваниями и раком молочной железы // Цитокины и воспаление. – 2006 – Т. 5, No1. – С. 37-43.
(check this in PDF content)
2
Литовкин K.В, Доменюк В.П., Бубнов В.В., Запорожан В.Н. Полиморфизм –174G/C в промоторе гена IL-6 у больных раком молочной железы и миомой матки: популяционный анализ на основе сравнения контрольной и опытных групп – http: // www.exp-oncology.com.ua/ru/ archives/33/650.html.
(check this in PDF content)
3
Родионов С.Ю., Черешнев В.А., Орлова Е.Г., Тараненко Л.А., Сибиряк С.В., Орлов О.А., Шур Н.Н., Крапивина О.А., Суховая Д.А. Содержание сывороточных цитокинов у онкологических больных при иммуно- и полихимиотерапии с применением альфа-фетопротеина человека // Цитокины и воспаление. – 2007.– Т. 6, No 3. – С. 36-39.
(check this in PDF content)
4
Тугуз А.Р., Анисимова Н.Ю., Вершинина М.В. Соотношение основных цитокинов в крови онкологических больных и здоровых доноров// Иммунология. – 2003. – Т. 3. – С. 184 - 186.
(check this in PDF content)
5
Чердынцева Н.В., Перельмутер В.М., Слонимская Е.М., Литвяков Н.В., Стахеева М.Н., Гарбуков Е.Ю., Завьялова М.В., Глущенко С.А., Малиновская Е.А., Дорошенко А.В., Красулина Н.А. Молекулярно-генетические факторы прогрессии как критерии прогноза у больных со злокачественными новообразованиями молочной железы // Российский Онкологический Портал. X Российский онкологический конгресс. – М., 2006.
(check this in PDF content)
6
Balasubramanian S.P., Azmy I.A.F., Higham S.E., Wilson A.G., Cross S.S., Cox A., Brown N., Reed M.W. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review // BMC Cancer. – 2006. – Vol. 188, N 6. – http: // www.biomedcentral. com/1471 - 2407/ 6/188.
(check this in PDF content)
7
Bland J. M., Altman D.G. Education and debate. The odds ratio // BMJ. – 2000. – Vol. 320. – P. 1468 .
(check this in PDF content)
8
Brower V. Researchers Attempting To Define Role of Cytokines in Cancer Risk // Journal of the National Cancer Institute. – 2005. – Vol. 97, N 16. – P. 1175-1177.
(check this in PDF content)
9
Cantagrel A., Navaux F., Loubet-Lessonlie P. IL-1beta, IL-1 receptor antagonist, IL-4, and IL - 10 gene polymorphisms // Arthr Rheum. – 1999.– Vol. 42, N 6. – P. 1093-1100.
(check this in PDF content)
10
Caruso C., Lio D., Cavallone L., Franceschi C. Aging, Longevity, Inflammation, and Cancer // Ann. N.Y. Acad. Sci. – 2004. – Vol. 1028. – P. 1-13 .
(check this in PDF content)
11
Choi E., Lee H. J., Yoo T., Chanock S.A. Common haplotype of interleukin-4 gene IL - 4 is associated with severe respiratory syncytial virus disease in Korean children // The Journal of Infectious Diseases. – 2002. – Vol. 186. – P. 1207 - 1211.
(check this in PDF content)
12
Conze D., Weiss L., Regen P. S., Bhushan A., Weaver D., Johnson P., Rincon M. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells // Cancer Res. – 2001. – Vol. 61. – P. 8851-8858.
(check this in PDF content)
13
DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T., Stadtmauer E., Weber B. Interleukin-6 (IL-6) – 174G/C gene polymorphism and outcome after high dose chemotherapy (HDC) and autologous peripheral stem cell transplant (PSCT) for high risk breast cancer // Proc. Am. Soc. Clin. Oncol. – 2002. – Vol. 21. – P. 170.
(check this in PDF content)
14
DeMichele A., Martin A.-M., Mick R., Gor P., Wray L., Klein-Cabra M., Athanasiadis G., Colligan T., Stadtmauer E., Weber B. Interleukin-6 – 174G→C polymorphism is associated with improved outcome in high-risk breast cancer // Cancer Res. – 2003. – Vol. 63, N 22. – P. 8051-8056.
(check this in PDF content)
15
DeMichele A.D., Martin A.-M., Weber B.L. IL - 6 variants as modifiers of breast cancer outcome // Proc. Amer. Assoc. Cancer Res. – 2004. – Vol. 45. – P. 1316-1317.
(check this in PDF content)
16
Fernandez-Real J.-M., Vendrell J., Richart C., Gutierrez C., Ricart W. Platelet count and Interleukin 6 Gene polymorphism in healthy subjects // BMC Medical Genetics. – 2001. – Vol. 2(6). – http:// www.biomedcentral.com/1471-2350/2/6.
(check this in PDF content)
17
Gоосh J.L., Lee A.V., Yee D. Interleukin-4 inhibits growth and induces apoptosis in human breast cancer cells // Cancer research.– 1998. – Vol. 58. – P. 4199-4205.
(check this in PDF content)
18
Guzowski D., Chandrasekaran A., Gawel C., Palma J., Koenig J., Ping Wang X., Dosik M., Kaplan M., Chu C.C., Chavan S., Furie R., Albesiano E., Chiorazzi N., Goodwin L. Analysis of Single Nucleotide Polymorphisms in the Promoter Region of Interleukin-10 by Denaturing HighPerformance Liquid Chromatography // Journal of Biomolecular Techniques. – 2005. – Vol. 16. – P. 154-166.
(check this in PDF content)
19
Heneghan M.A., Johnson P.J., Clare M., Ho S., Harrison P.M., Donaldson P.T. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese // Int. J. Gastrointest Cancer. – 2003. – Vol. 34, N 1. – P. 19-26.
(check this in PDF content)
20
Howell W.M., Rose-Zerilli M.J. Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis // National Blood J. Nutr. – 2007. – Vol. 137. – P. 194-199.
(check this in PDF content)
21
Hsieh Y.Y., Chang C.C., Tsai C.H., Lin C.C., Tsai F.J. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta - 511 promoter, 3953 exon 5, receptor antagonist), IL-2 14, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma // Fertil Steril. – 2007. – Vol. 87 (4), – P. 886- 895.
(check this in PDF content)
22
Kleinrath T., Gassner C., Lackner P., Thurnher M., Ramoner R. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma // J. Clin. Oncol.– 2007.– Vol. 25, N 7. – P. 845-851.
(check this in PDF content)
23
Kundu N., Beaty T.L., Jackson M.J., Fulton A.M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer // J. Natl. Cancer Inst. – 1996. – Vol. 88, N 8. – P. 536 - 541.
(check this in PDF content)
24
Langsenlehner U., KriPl P., Renner W., Yazdani-Biuki B., Eder T., Köppel H., Wascher T.C., Paulweber B., Samonigg H. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk // Breast Cancer Research and Treatment. – 2005. – Vol. 90, N 2. – P. 113-115.
(check this in PDF content)
25
Mock C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus // Arthritis Rheum. – 1998. – Vol. 41. – P. 1090-1095.
(check this in PDF content)
26
Nagai S., Toi M. Interleukin-4 and breast cancer // Breast Cancer. – 2000. – Vol. 7(3). – P. 181 - 186.
(check this in PDF content)
27
Nishimura R., Nagao K., Miyayama H., Matsuda M., Baba K., Matsuoka Y.,Yamashita H., Fukuda M., Mizumoto T., Hamamoto R. An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer // Oncology. – 2000. – Vol. 59. – P. 166-173.
(check this in PDF content)
28
Purohit A., Newman P.S., Reed M. J. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer // Breast Cancer Res. – 2002. – Vol. 4. – P. 65-69.
(check this in PDF content)
29
Slattery M.L., Curtin K., Baumgartner R., Sweeney C., Byers T., Giuliano A.R., Baumgartner K.B., Wolff R.R. IL-6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States // Cancer Epidemiol Biomarkers Prev. – 2007. – Vol. 16, N 4. – P. 747-755.
(check this in PDF content)
30
Smith K.C., Bateman A.C., Fussell H.M., Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis // European Journal of Immunogenetics. – 2004. – Vol. 31, N 4. – P. 167-173.
(check this in PDF content)
31
Vairaktaris E., Yannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., Nkenke E., Critselis E., Avgoustidis D., Yapijakis C., Neukam F.W., Patsouris E. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans // Oral Surg Oral Med Oral Pathol Oral Radiol Endod. – 2007. – Vol. 104, N 6. – P. 796-802.
(check this in PDF content)
32
Venetsanakos E., Beckman I., Bradley J., Skinner J.M. High incidence of interleukin-10 mRNA but not interleukin-2 mRNA detected in human breast tumours // Br. J. Cancer. – 1997. – Vol. 75, N 12. – P. 1826-1830.
(check this in PDF content)
33
Yannopoulos A., Nikiteas N., Chatzitheofylaktou A., Tsigris C. The (-590 C/T) polymorphism in the interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma // In Vivo. – 2007. – Vol. 21, N 6. – P. 1031-1035.
(check this in PDF content)
34
Yokoe T., Iino Y., Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report // Breast Cancer. – 2000. – Vol. 7. – P. 187-190.
(check this in PDF content)
35
Zhang G.J., Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma // Anticancer Res. – 1999. – Vol. 19. – P. 1427-1432. поступила в редакцию 23.09.2008
(check this in PDF content)